These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22168396)

  • 1. Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?
    Daly A; Gokmen-Ozel H; MacDonald A; Preece MA; Davies P; Chakrapani A; McKiernan P
    J Hum Nutr Diet; 2012 Apr; 25(2):111-6. PubMed ID: 22168396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosinaemia type II: an easily diagnosed metabolic disorder with a rewarding therapeutic response.
    al-Essa MA; Rashed MS; Ozand PT
    East Mediterr Health J; 1999 Nov; 5(6):1204-7. PubMed ID: 11924112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome.
    Bärhold F; Meyer U; Neugebauer AK; Thimm EM; Lier D; Rosenbaum-Fabian S; Och U; Fekete A; Möslinger D; Rohde C; Beblo S; Hochuli M; Bogovic N; Korpel V; Dahl SV; Mayorandan S; Fischer A; Freisinger P; Dokoupil K; Heddrich-Ellerbrok M; Jörg-Streller M; van Teeffelen-Heithoff A; Lahl J; Das AM
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396520
    [No Abstract]   [Full Text] [Related]  

  • 4. Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1.
    van Ginkel WG; van Vliet D; Burgerhof JGM; de Blaauw P; Rubio Gozalbo ME; Heiner-Fokkema MR; van Spronsen FJ
    PLoS One; 2017; 12(9):e0185342. PubMed ID: 28949985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia.
    Wilson CJ; Van Wyk KG; Leonard JV; Clayton PT
    J Inherit Metab Dis; 2000 Nov; 23(7):677-83. PubMed ID: 11117429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and intellectual functioning in patients with tyrosinemia type I.
    Pohorecka M; Biernacka M; Jakubowska-Winecka A; Biernacki M; Kuśmierska K; Kowalik A; Sykut-Cegielska J
    Pediatr Endocrinol Diabetes Metab; 2012; 18(3):96-100. PubMed ID: 23146787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
    Al-Dhalimy M; Overturf K; Finegold M; Grompe M
    Mol Genet Metab; 2002 Jan; 75(1):38-45. PubMed ID: 11825062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I.
    Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.
    Yilmaz O; Daly A; Pinto A; Ashmore C; Evans S; Gupte G; Santra S; Preece MA; Mckiernan P; Kitchen S; Ayhan NY; MacDonald A
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing.
    van Spronsen FJ; van Rijn M; van Dijk T; Smit GP; Reijngoud DJ; Berger R; Heymans HS
    Pediatrics; 1993 Oct; 92(4):570-3. PubMed ID: 8414829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid concentrations of large neutral and basic amino acids in Macaca mulatta: diurnal variations and responses to chronic changes in dietary protein intake.
    Grimes MA; Cameron JL; Fernstrom JD
    Metabolism; 2009 Jan; 58(1):129-40. PubMed ID: 19059540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utilization of dried blood spot nitisinone (NTBC) and succinylacetone (SA) concentrations in hereditary tyrosinaemia type 1 - A UK centre experience.
    Yeo M; Turner C; Dalton NR; Rahman Y; Vara R
    Ann Clin Biochem; 2020 Nov; 57(6):412-419. PubMed ID: 32936663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients.
    van Ginkel WG; van Reemst HE; Kienstra NS; Daly A; Rodenburg IL; MacDonald A; Burgerhof JGM; de Blaauw P; van de Krogt J; Santra S; Heiner-Fokkema MR; van Spronsen FJ
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional and behavioural functioning in children with tyrosinaemia type 1.
    Pohorecka M; Biernacki M; Jakubowska-Winecka A; Leszczynska-Iwanicka K; Rokicki D; Pokora P; Perkowska B; Pajdowska M; Biernacka M
    Pediatr Endocrinol Diabetes Metab; 2024; 30(1):8-13. PubMed ID: 39026474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations.
    Grünert SC; Brichta CM; Krebs A; Clement HW; Rauh R; Fleischhaker C; Hennighausen K; Sass JO; Schwab KO
    Nutr J; 2013 May; 12():60. PubMed ID: 23672685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1.
    De Laet C; Munoz VT; Jaeken J; François B; Carton D; Sokal EM; Dan B; Goyens PJ
    Dev Med Child Neurol; 2011 Oct; 53(10):962-4. PubMed ID: 21745202
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
    Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
    J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24-Hour protein, arginine and citrulline metabolism in fed critically ill children - A stable isotope tracer study.
    de Betue CTI; Garcia Casal XC; van Waardenburg DA; Schexnayder SM; Joosten KFM; Deutz NEP; Engelen MPKJ
    Clin Nutr; 2017 Jun; 36(3):876-887. PubMed ID: 28089618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients.
    van Vliet K; van Ginkel WG; Jahja R; Daly A; MacDonald A; De Laet C; Vara R; Rahman Y; Cassiman D; Eyskens F; Timmer C; Mumford N; Bierau J; van Hasselt PM; Gissen P; Goyens PJ; McKiernan PJ; Wilcox G; Morris AAM; Jameson EA; Huijbregts SCJ; van Spronsen FJ
    Orphanet J Rare Dis; 2019 Dec; 14(1):285. PubMed ID: 31801588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report on inverse diurnal variation of phenylalanine: implications in maternal phenylketonuria.
    Farquhar DL; Steven F; Westwood A
    Hum Nutr Appl Nutr; 1985 Jun; 39(3):224-6. PubMed ID: 4044289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.